跳至主要内容
临床试验/CTRI/2019/09/021423
CTRI/2019/09/021423招募中未知

An Open Label Single Arm Clinical Study To Evaluate The Efficacy AndSafety Of Psoramit Ointment In patients suffering from mild tomoderate Psoriasis

The Himalaya Drug Company0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subject with symptoms of mild to moderate psoriasis with PASI score <10
  • Subject diagnosed with Mild to moderate chronic plaque psoriasis with
  • Palmoplantar psoriasis, Guttate psoriasis, Flexural psoriasis
  • Age >18 to 65 years, both male and female subjects.
  • Physician Global Assessment score of <2
  • Patients willing to sign inform consent document.

排除标准

  • Patients with Pustular psoriasis, Erythrodermic psoriasis and psoriatic
  • Subjects treated with other medications / steroids.
  • Significant medical problems such as uncontrolled hypertension /
  • congestive heart failure or any other medication condition
  • Pregnant & Breast feeding Women.
  • History of ongoing, chronic or recurrent infectious disease /
  • lymphoproliferative disease or history of malignancy of any organ
  • system within the past 5 years.
  • History of Alcohol or smoking abuse.

研究者

相似试验